Carvedilol Alone or in Combination with Digoxin for the Management of Atrial Fibrillation in Patients with Heart Failure?

Journal of the American College of Cardiology

Volumn 42, Issue 11, 2003, Pages 1944-1951

  Khand, Aleem U ^b   Rankin, Andrew C ^a   Martin, William ^a   Taylor, Jacqueline ^a   Gemmell, Islay ^c   Cleland, John G F ^b,d  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d Castlehill Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; DIGOXIN; PLACEBO;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; ELECTROCARDIOGRAPHY; EXERCISE; FATIGUE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE; HUMAN; MALE; PATIENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; TIME; WALKING;

EID: 0344873704     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.07.020     Document Type: Article

References (25)

1. Farshi R, Kistner D, Sarma JSM, Longmate JA, Singh BN. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol 1999;33:304-10.
2. Garg R, Gorlin R, Smith T, Yusuf S. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
3. Packer M, Bristow MR, Cohn JN, et al., the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
4. The CIBIS-II Investigators and Committees. The Cardiac Insufficiency BIsoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
5. Joglar JA, Acusta AP, Schusterman NH, et al. Effect of carvedilol on survival and haemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the U.S. Carvedilol Heart Failure Trials Program. Am Heart J 2001;142:498-501.
6. Kudoh M. Clinical studies on long-term combined therapy of digitalis and xamoterol for patients with mild and moderate congestive heart failure accompanied by atrial fibrillation. Tokyo Med J 1988;16:65-74.
7. Yahalom J, Klein HO, Kaplinsky E. Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation. Chest 1977;71:592-6.
8. Cristodorescu R, Rosu D, Deutsch G, Verdes A, Luca C. The heart rate slowing effect of pindolol in patients with digitalis resistant atrial fibrillation and heart failure. Med Interne 1986;24:207-15.
9. Bacharach SL, Green MV, Bonow RO, Findley SL, Ostrow HG, Johnston GS. Measurement of ventricular function by ECG gating during atrial fibrillation. J Nucl Med 1981;22:226-31.
10. Packer M, Antonopoulos GV, Berlin JA, Chittams J, Konstam MA, Udelson JE. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. Am Heart J 2001;141:899-907.
11. Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinorrhythmometry. Chronobiologia 1979;6:305-23.
12. Khand AU, Rankin AC, Kaye G, Cleland JGF. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 2000;21:614-32.
13. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings. Circulation 1989;80:65-77.
14. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin converting enzyme inhibitors. N Engl J Med 1993;329:1-7.
15. Inagaki S, Adachi H, Sugihara H, et al. Left ventricular function during atrial fibrillation assessed by left ventricular function curves using ECG-gated blood pool scintigraphy. J Cardiogr 1986;16:949-61.
16. Batin PD, Hawkins M, Cowley AJ. Patterns of neuroendocrine activation at rest and during exercise following acute myocardial infarction. Eur Heart J 1994;15:1552-7.
17. Colluci WS, Elkayam U, Horton PP, Abraham WT, Bourge RC, the Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide in the treatment of decompensated congestive heart failure. N Engl J Med 2000;343:253-64.
18. Lechat P, Hulot J, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in the CIBIS II trial. Circulation 2001;103:1428-33.
19. Eichorn EJ, Lukas MA, Wu B, et al. Effect of concomitant digoxin and carvedilol therapy on mortality and morbidity in patients with chronic heart failure. Am J Cardiol 2000;86:1032-5.
20. Poole-Wilson PA, Swedberg K, Cleland JG, et al., Carvedilod Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET). Lancet 2003;362:7-13.
21. Goldstein RE, Boccuzzi SJ, Cruess D. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
22. Deedwania PC, Singh BN, Ellenbogen KA, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Circulation 1998;98:2574-9.
23. Hohnloser SH, Kuck KH, Lillenthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-94.
24. The AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347: 1825-33.
25. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.